NeuroPace develops the RNS System, the only FDA-approved epilepsy device that responds to abnormal brain activity to stop seizures at their source, providing personalized treatment and improving patient care.

NeuroPace develops the RNS System, the only FDA-approved epilepsy device that responds to abnormal brain activity to stop seizures at their source, providing personalized treatment and improving patient care.

MindMate is an application that helps people living with cognitive decline. The MindMate allows its users to learn within the app to reduce the risk of cognitive decline, such as Alzheimer's, and Dementia. The company is driven by a mission to Improve brain health, reduce the risk of developing Alzheimer's and Dementia with healthy and delicious recipes, physical exercises and mental exercises. MindMate has received several awards including the Enterprise Pathway Challenge Winner, Young Innovators Challenge 2015 overall Winner, Most Promising Postgraduate Business at The University of Glasgow and Santander 60 second Pitch Award. MindMate was founded in 2015 and is headquartered in Santa Monica, California.

MindMate is an application that helps people living with cognitive decline. The MindMate allows its users to learn within the app to reduce the risk of cognitive decline, such as Alzheimer's, and Dementia. The company is driven by a mission to Improve brain health, reduce the risk of developing Alzheimer's and Dementia with healthy and delicious recipes, physical exercises and mental exercises. MindMate has received several awards including the Enterprise Pathway Challenge Winner, Young Innovators Challenge 2015 overall Winner, Most Promising Postgraduate Business at The University of Glasgow and Santander 60 second Pitch Award. MindMate was founded in 2015 and is headquartered in Santa Monica, California.